Jim Simons Kezar Life Sciences, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Kezar Life Sciences, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,297,074 shares of KZR stock, worth $8.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,297,074

Previous 778,474 66.62%

Holding current value

$8.46 Million

Previous $467,000 113.7%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.53 - $0.77 $274,858 - $399,322	518,600 Added 66.62%	1,297,074 $998,000
Q2 2024 Aug 09, 2024	SELL	$0.6 - $0.92 $335,760 - $514,832	-559,600 Reduced 41.82%	778,474 $467,000
Q1 2024 May 13, 2024	BUY	$0.8 - $1.05 $36,924 - $48,462	46,155 Added 3.57%	1,338,074 $1.21 Million
Q4 2023 Feb 13, 2024	BUY	$0.72 - $1.15 $491,920 - $785,706	683,223 Added 112.24%	1,291,919 $1.22 Million
Q3 2023 Nov 14, 2023	SELL	$1.08 - $2.54 $51,068 - $120,106	-47,286 Reduced 7.21%	608,696 $724,000
Q2 2023 Aug 11, 2023	SELL	$2.31 - $3.06 $91,711 - $121,488	-39,702 Reduced 5.71%	655,982 $1.61 Million
Q1 2023 May 12, 2023	BUY	$3.13 - $7.31 $1.92 Million - $4.48 Million	612,584 Added 737.16%	695,684 $2.18 Million
Q4 2022 Feb 13, 2023	BUY	$6.39 - $8.8 $213,758 - $294,377	33,452 Added 67.38%	83,100 $585,000
Q3 2022 Nov 14, 2022	SELL	$7.99 - $10.75 $518,966 - $698,234	-64,952 Reduced 56.68%	49,648 $427,000
Q2 2022 Aug 12, 2022	SELL	$4.58 - $17.13 $721,808 - $2.7 Million	-157,600 Reduced 57.9%	114,600 $948,000
Q1 2022 May 13, 2022	SELL	$12.3 - $18.33 $713,400 - $1.06 Million	-58,000 Reduced 17.57%	272,200 $4.52 Million
Q4 2021 Feb 11, 2022	SELL	$7.44 - $16.72 $15,028 - $33,774	-2,020 Reduced 0.61%	330,200 $5.52 Million
Q3 2021 Nov 12, 2021	BUY	$4.85 - $9.73 $31,039 - $62,272	6,400 Added 1.96%	332,220 $2.87 Million
Q2 2021 Aug 13, 2021	SELL	$4.93 - $6.46 $1,479 - $1,938	-300 Reduced 0.09%	325,820 $1.77 Million
Q1 2021 May 13, 2021	SELL	$5.24 - $6.99 $124,712 - $166,362	-23,800 Reduced 6.8%	326,120 $1.94 Million
Q4 2020 Feb 10, 2021	BUY	$4.77 - $6.58 $101,123 - $139,496	21,200 Added 6.45%	349,920 $1.83 Million
Q3 2020 Nov 13, 2020	SELL	$4.36 - $5.5 $470,444 - $593,450	-107,900 Reduced 24.71%	328,720 $1.59 Million
Q2 2020 Aug 13, 2020	BUY	$3.6 - $7.75 $1.31 Million - $2.83 Million	365,200 Added 511.34%	436,620 $2.26 Million
Q1 2020 May 14, 2020	SELL	$2.77 - $5.75 $831 - $1,725	-300 Reduced 0.42%	71,420 $311,000
Q4 2019 Feb 13, 2020	SELL	$2.5 - $4.26 $22,450 - $38,254	-8,980 Reduced 11.13%	71,720 $288,000
Q3 2019 Nov 13, 2019	BUY	$3.0 - $7.58 $242,100 - $611,706	80,700 New	80,700 $265,000

Others Institutions Holding KZR

# of Institutions

Shares Held

38.4M

Call Options Held

13.8K

Put Options Held

600

View Full List

About Kezar Life Sciences, Inc.

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $446M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

More about KZR

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account